Hisun Pharm Hangzhou Company Profile
✉ Email this page to a colleague
What is the competitive landscape for HISUN PHARM HANGZHOU, and what generic and branded alternatives to HISUN PHARM HANGZHOU drugs are available?
HISUN PHARM HANGZHOU has twenty approved drugs.
Drugs and US Patents for Hisun Pharm Hangzhou
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hisun Pharm Hangzhou | OLANZAPINE | olanzapine | TABLET;ORAL | 206924-002 | Dec 31, 2020 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Hisun Pharm Hangzhou | DONEPEZIL HYDROCHLORIDE | donepezil hydrochloride | TABLET;ORAL | 202410-001 | Mar 24, 2017 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Hisun Pharm Hangzhou | TICAGRELOR | ticagrelor | TABLET;ORAL | 208575-001 | Jan 23, 2019 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Hisun Pharm Hangzhou | DOXORUBICIN HYDROCHLORIDE | doxorubicin hydrochloride | INJECTABLE;INJECTION | 206062-001 | May 13, 2019 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Hisun Pharm Hangzhou | OLANZAPINE | olanzapine | TABLET, ORALLY DISINTEGRATING;ORAL | 206892-001 | Dec 31, 2020 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Hisun Pharm Hangzhou | IRINOTECAN HYDROCHLORIDE | irinotecan hydrochloride | INJECTABLE;INJECTION | 090016-001 | Jan 28, 2009 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.